Replies to post #370566 on Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

The entry level of Nasdaq....Nasdaq Capital Markets...doesn't have an initial listing revenue requirement.
https://listingcenter.nasdaq.com/assets/initialguide.pdf

[loanranger]

In response to your post I earlier answered that "The entry level of Nasdaq....Nasdaq Capital Markets...doesn't have an initial listing revenue requirement" and that wasn't accurate. The rule is complicated.

(1) (A) Minimum bid price of $4 per share; or

(B) Minimum closing price of $3 per share, if the Company meets the requirements of the Equity or Net Income Standards under Rules 5505(b)(1) or (b)(3), or of $2 per share, if the Company meets the requirements of the Market Value of Listed Securities Standard under Rule 5505(b)(2), provided that in either case the Company must also demonstrate that it has net tangible assets (i.e., total assets less intangible assets and liabilities) in excess of $2 million, if the issuer has been in continuous operation for at least three years; or net tangible assets in excess of $5 million, if the issuer has been in continuous operation for less than three years; or average revenue of at least $6 million for the last three years. A security must meet the applicable closing price requirement for at least five consecutive business days prior to approval.

IPIX doesn't meet either of the Equity, Net Income or Market Value requirements.
Sorry for any confusion.